RSS   Newsletter   Contact   Advertise with us
Post Online Media

VistaGen names VP, corporate development and investor relations

VistaGenVistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, appointed Mark A. McPartland as vice president, corporate development and investor relations.
Article continues below

READ MORE Regulus names VP, investor relations & corporate communications

Prior to joining VistaGen, Mr. McPartland served as the Vice President of Corporate Development and Communications at Stellar Biotechnologies, Inc..

Prior to Stellar, Mr. McPartland served as Senior Vice President at MZ Group, a subsidiary of @titude Global, the world's largest independent global IR consulting firm.

His prior experience includes Vice President and Partner at Alliance Advisors, LLC where he specialized in the implementation of capital markets strategy, market positioning and financial communications, and Regional Vice President of Hayden Communications, Inc. where he led investor relations and corporate communications programs for micro and small cap companies.

Mr. McPartland received his Bachelors in Business Administration and Marketing from Coastal Carolina University.



We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy